Latest Quarter
2026-04-06
Asarfi Hospital Ltd (ASARFI.BO)
Revenue
$714M
Net Income
$62.4M
Operating Margin
11.2%
Free Cash Flow
-$161M
Debt / Assets
50.6%
Values are in USD and rounded to the nearest whole number unless noted.
Swipe horizontally to view all columns.
| Income Statement (Quarterly) | 2026-04-06 | 2025-09-30 | 2025-06-30 | 2024-12-31 |
|---|---|---|---|---|
| Revenue | 713,622,000 | 713,622,000 | 356,811,000 | 328,901,000 |
| Cost of Revenue | 171,476,000 | 171,476,000 | 85,738,000 | 71,811,000 |
| Gross Profit | 542,146,000 | 542,146,000 | 271,073,000 | 257,090,000 |
| Operating Expenses | ||||
| R&D Expenses | 0 | 0 | 0 | 0 |
| SG&A Expenses | 0 | 0 | 0 | 0 |
| Operating Expenses | 462,174,000 | 462,174,000 | 231,087,000 | 218,043,000 |
| Operating Income | 79,972,000 | 79,972,000 | 39,986,000 | 39,047,000 |
| Interest Expense | 24,376,000 | 24,376,000 | 12,188,000 | 11,750,000 |
| Income Before Tax | 83,922,000 | 83,922,000 | 41,961,000 | 36,244,000 |
| Income Tax Expense | 21,500,000 | 21,500,000 | 10,750,000 | 9,396,000 |
| Net Income | 62,422,000 | 62,422,000 | 31,211,000 | 26,849,000 |
| Per Share | ||||
| EPS | 3.18 | 3.18 | 1.59 | 1.36 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Statement (Annual) | 2025-03-31 | 2024-03-31 |
|---|---|---|
| Revenue | 1,205,657,000 | 844,004,000 |
| Cost of Revenue | 278,592,000 | 203,315,000 |
| Gross Profit | 927,065,000 | 640,689,000 |
| Operating Expenses | ||
| R&D Expenses | 0 | 0 |
| SG&A Expenses | 0 | 178,847,000 |
| Operating Expenses | 818,344,000 | 566,442,000 |
| Operating Income | 108,721,000 | 74,247,000 |
| Interest Expense | 40,809,000 | 24,407,000 |
| Income Before Tax | 143,111,000 | 62,910,000 |
| Income Tax Expense | 37,348,000 | 21,294,000 |
| Net Income | 105,762,000 | 41,616,000 |
| Per Share | ||
| EPS | 5.36 | 2.31 |
| EPS Diluted | 0.00 | 0.00 |
| Balance Sheet (Quarterly) | 2025-03-31 | 2024-03-31 |
|---|---|---|
| Assets | ||
| Cash and Cash Equivalents | 14,263,000 | 175,955,000 |
| Short Term Investments | 0 | 0 |
| Net Receivables | 406,734,000 | 242,824,000 |
| Inventory | 22,767,000 | 17,999,000 |
| Total Current Assets | 584,844,000 | 467,524,000 |
| Property Plant Equipment | 1,035,835,000 | 937,664,000 |
| Goodwill and Intangibles | 0 | 0 |
| Total Assets | 1,638,867,000 | 1,540,882,000 |
| Liabilities | ||
| Account Payables | 130,357,000 | 248,574,000 |
| Short Term Debt | 147,280,000 | 115,908,000 |
| Total Current Liabilities | 410,392,000 | 414,797,000 |
| Long Term Debt | 338,293,000 | 203,214,000 |
| Total Liabilities | 829,035,000 | 836,812,000 |
| Shareholders Equity | ||
| Retained Earnings | 0 | 247,929,000 |
| Total Shareholders Equity | 809,832,000 | 704,070,000 |
| Balance Sheet (Annual) | 2025-03-31 | 2024-03-31 |
|---|---|---|
| Assets | ||
| Cash and Cash Equivalents | 14,263,000 | 175,955,000 |
| Short Term Investments | 0 | 0 |
| Net Receivables | 406,734,000 | 242,824,000 |
| Inventory | 22,767,000 | 17,999,000 |
| Total Current Assets | 584,844,000 | 467,524,000 |
| Property Plant Equipment | 1,035,835,000 | 937,664,000 |
| Goodwill and Intangibles | 0 | 0 |
| Total Assets | 1,638,867,000 | 1,540,882,000 |
| Liabilities | ||
| Account Payables | 130,357,000 | 248,574,000 |
| Short Term Debt | 147,280,000 | 115,908,000 |
| Total Current Liabilities | 410,392,000 | 414,797,000 |
| Long Term Debt | 338,293,000 | 203,214,000 |
| Total Liabilities | 829,035,000 | 836,812,000 |
| Shareholders Equity | ||
| Retained Earnings | 0 | 247,929,000 |
| Total Shareholders Equity | 809,832,000 | 704,070,000 |
| Cash Flow Statement (Quarterly) | 2025-03-31 | 2024-03-31 |
|---|---|---|
| Operating Activities | ||
| Net Income | 105,762,000 | 41,616,000 |
| Depreciation & Amortization | 126,760,000 | 87,875,000 |
| Stock Based Compensation | 0 | 0 |
| Change in Working Capital | -278,037,000 | -106,394,000 |
| Operating Cash Flow | -43,498,000 | 260,741,000 |
| Investing Activities | ||
| Capital Expenditure | -117,872,000 | -460,739,000 |
| Investments | -117,872,000 | -460,739,000 |
| Investing Cash Flow | -73,839,000 | -630,899,000 |
| Financing Activities | ||
| Debt Repayment | 166,451,000 | 147,102,000 |
| Common Stock Issued/Repurchased | 0 | 231,027,000 |
| Dividends Paid | 0 | 0 |
| Financing Cash Flow | 125,688,000 | 364,068,000 |
| Summary | ||
| Free Cash Flow | -161,370,000 | -199,998,000 |
| Net Change in Cash | 8,351,000 | -6,090,000 |
| Cash Flow Statement (Annual) | 2025-03-31 | 2024-03-31 |
|---|---|---|
| Operating Activities | ||
| Net Income | 105,762,000 | 41,616,000 |
| Depreciation & Amortization | 126,760,000 | 87,875,000 |
| Stock Based Compensation | 0 | 0 |
| Change in Working Capital | -278,037,000 | -106,394,000 |
| Operating Cash Flow | -43,498,000 | 260,741,000 |
| Investing Activities | ||
| Capital Expenditure | -117,872,000 | -460,739,000 |
| Investments | -117,872,000 | -460,739,000 |
| Investing Cash Flow | -73,839,000 | -630,899,000 |
| Financing Activities | ||
| Debt Repayment | 166,451,000 | 147,102,000 |
| Common Stock Issued/Repurchased | 0 | 231,027,000 |
| Dividends Paid | 0 | 0 |
| Financing Cash Flow | 125,688,000 | 364,068,000 |
| Summary | ||
| Free Cash Flow | -161,370,000 | -199,998,000 |
| Net Change in Cash | 8,351,000 | -6,090,000 |